![Lixte Biotechnology Holdings Inc](/common/images/company/N_LIXTW.png)
Lixte Biotechnology Holdings Inc (LIXTW)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -414.161 | -200.777 | -74.777 | -69.625 | -82.658 | -130.375 | -118.521 | -103.09 |
Return on Equity (%) | -810.247 | -298.843 | -83.304 | -74.39 | -87.698 | -137.278 | -126.831 | -111.07 |
Return on Invested Capital (%) | -810.247 | -299.008 | -83.532 | -75.938 | -87.725 | -137.135 | -126.791 | -111.135 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.068 | -0.043 | 0.009 | -0.016 | 0.12 | 0.093 | 0.098 | 0.19 |
Earnings Per Share | -0.044 | -0.031 | -0.032 | -0.036 | -0.26 | -0.483 | -0.371 | -1.957 |
Cash Per Share | 0.004 | 0.022 | 0.064 | 0.039 | 0.403 | 0.347 | 0.315 | 1.617 |
Working Capital Per Share | 0.004 | 0.017 | 0.061 | 0.036 | 0.399 | 0.344 | 0.304 | 1.537 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.044 | -0.031 | -0.032 | -0.036 | -0.26 | -0.483 | -0.371 | -1.957 |
EBITDA Per Share | -0.044 | -0.031 | -0.032 | -0.036 | -0.26 | -0.483 | -0.371 | -1.957 |
Free Cash Flow Per Share | -0.044 | -0.031 | -0.032 | -0.036 | -0.26 | -0.483 | -0.371 | -1.957 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 47,88M | 58,03M | 67,05M | 67,05M | 12,4M | 13,75M | 16,65M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 16,65M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 89,51k |
Ratio cours/bénéfice | -0,73 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,88 |
Ratio prix/valeur comptable | 0,93 |
Rendement de dividende | - |
Actions en circulation | 2,25M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales